ADMA Biologics Inc (ADMA) vs Precigen, Inc. (PGEN)
- ADMA Biologics Inc ADMA 10.68 −0.47%
- Precigen, Inc. PGEN 6.35 −11.81%
ADMA Biologics Inc and Precigen, Inc. are both Biotechnology companies. ADMA Biologics Inc and Precigen, Inc. are of similar size ($2.6B and $2.4B). Precigen, Inc. has negative trailing earnings, so its P/E is not meaningful; ADMA Biologics Inc trades at 14.8×. Precigen, Inc. grew revenue faster over the last twelve months: 1,875.1% against 8.04%. ADMA Biologics Inc has the higher net margin (33.0% vs −392.8%) and the higher return on invested capital (29.8% vs −24.9%). Across the 18 metrics below, ADMA Biologics Inc leads on 16 and Precigen, Inc. on 2.
Valuation
Profitability
| Metric | ADMA | PGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.71% | 90.67% | 65.16% |
| Operating margin | 43.82% | (46.08%) | 0.00% |
| Net margin | 32.98% | (392.81%) | 0.00% |
| Free cash flow margin | 22.69% | (134.42%) | 0.00% |
| Return on equity | 41.90% | (9,907.46%) | (56.36%) |
| Return on assets | 27.19% | (247.40%) | (48.04%) |
| Return on invested capital | 29.78% | (24.87%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack